Jendle J - Search Results

1

Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority study.

Blonde L, Jendle J, Gross J, Woo V, Jiang H, Fahrbach JL, Milicevic Z. Blonde L, et al. Among authors: jendle j. Lancet. 2015 May 23;385(9982):2057-66. doi: 10.1016/S0140-6736(15)60936-9. Lancet. 2015. PMID: 26009229 Clinical Trial.

2

Clinical Performance Evaluation of Continuous Glucose Monitoring Systems: A Scoping Review and Recommendations for Reporting.

Freckmann G, Eichenlaub M, Waldenmaier D, Pleus S, Wehrstedt S, Haug C, Witthauer L, Jendle J, Hinzmann R, Thomas A, Eriksson Boija E, Makris K, Diem P, Tran N, Klonoff DC, Nichols JH, Slingerland RJ. Freckmann G, et al. Among authors: jendle j. J Diabetes Sci Technol. 2023 Nov;17(6):1506-1526. doi: 10.1177/19322968231190941. Epub 2023 Aug 20. J Diabetes Sci Technol. 2023. PMID: 37599389 Review.

3

Model-based predictions on health benefits and budget impact of implementing empagliflozin in people with type 2 diabetes and established cardiovascular disease.

Nilsson K, Andersson E, Persson S, Karlsdotter K, Skogsberg J, Gustavsson S, Jendle J, Steen Carlsson K. Nilsson K, et al. Among authors: jendle j. Diabetes Obes Metab. 2023 Mar;25(3):748-757. doi: 10.1111/dom.14921. Epub 2022 Dec 2. Diabetes Obes Metab. 2023. PMID: 36371543 Free PMC article.

4

A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspective.

Jendle J, Adolfsson P, Choudhary P, Dovc K, Fleming A, Klonoff DC, Mader JK, Oliver N, Sherr JL, Šoupal J, Heinemann L. Jendle J, et al. Diabetologia. 2024 Feb;67(2):236-245. doi: 10.1007/s00125-023-06049-5. Epub 2023 Dec 2. Diabetologia. 2024. PMID: 38041737 Free PMC article. Review.

5

Burden of established cardiovascular disease in people with type 2 diabetes and matched controls: Hospital-based care, days absent from work, costs and mortality.

Persson S, Nilsson K, Karlsdotter K, Skogsberg J, Gustavsson S, Jendle J, Steen Carlsson K. Persson S, et al. Among authors: jendle j. Diabetes Obes Metab. 2023 Mar;25(3):726-734. doi: 10.1111/dom.14919. Epub 2022 Nov 28. Diabetes Obes Metab. 2023. PMID: 36371525 Free PMC article.

6

Insulin and GLP-1 analog combinations in type 2 diabetes mellitus: a critical review.

Jendle J, Martin SA, Milicevic Z. Jendle J, et al. Expert Opin Investig Drugs. 2012 Oct;21(10):1463-74. doi: 10.1517/13543784.2012.707190. Epub 2012 Jul 16. Expert Opin Investig Drugs. 2012. PMID: 22799463 Review.

7

Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program.

Jendle J, Grunberger G, Blevins T, Giorgino F, Hietpas RT, Botros FT. Jendle J, et al. Diabetes Metab Res Rev. 2016 Nov;32(8):776-790. doi: 10.1002/dmrr.2810. Epub 2016 May 15. Diabetes Metab Res Rev. 2016. PMID: 27102969 Review.

8

Continuous glucose monitoring in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonist dulaglutide in combination with prandial insulin lispro: an AWARD-4 substudy.

Jendle J, Testa MA, Martin S, Jiang H, Milicevic Z. Jendle J, et al. Diabetes Obes Metab. 2016 Oct;18(10):999-1005. doi: 10.1111/dom.12705. Epub 2016 Jul 22. Diabetes Obes Metab. 2016. PMID: 27279266 Clinical Trial.

9

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.

Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR; CANVAS Program Collaborative Group. Neal B, et al. N Engl J Med. 2017 Aug 17;377(7):644-657. doi: 10.1056/NEJMoa1611925. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605608 Free article. Clinical Trial.

10

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial.

Dandona P, Mathieu C, Phillip M, Hansen L, Griffen SC, Tschöpe D, Thorén F, Xu J, Langkilde AM; DEPICT-1 Investigators. Dandona P, et al. Lancet Diabetes Endocrinol. 2017 Nov;5(11):864-876. doi: 10.1016/S2213-8587(17)30308-X. Epub 2017 Sep 14. Lancet Diabetes Endocrinol. 2017. PMID: 28919061 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page